Six Months of Trastuzumab Effective in HER2+ Breast Cancer

A large-scale data analysis has confirmed that 6 months of trastuzumab is just as effective as 12 months in HER2+ early breast cancer, but the question is whether it will be adopted, say experts.

from Ob/Gyn & Women’s Health – Medscape http://www.medscape.com/viewarticle/959042
via IFTTT

robotic surgeon, gynecologic cancer treatment center, holistic oncologist

Design a site like this with WordPress.com
Get started